Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally

Cupid, a consumer wellness company, saw its shares surge 178% in 2026, driven by growing orders and expansion plans. This follows a 584% surge in 2025. The stock's recent rally has enhanced its market cap to ₹25,000 crore, benefiting retail investors significantly.